Immunohistochemistry showed positivity for CDK4 and MDM2, and fluorescence in situ hybridization confirmed MDM2 amplification, leading to a diagnosis of atypical lipomatous tumor/well‐differentiated liposarcoma. The gene discussed is CDK4; the disease is liposarcoma.